SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (4573)10/19/2000 10:39:35 AM
From: Extra Pale  Respond to of 10280
 
o We expect the company to discuss its DDMS product on the conference call
at 9AM this morning. DDMS is described by SEPR as a triple-mechanism compound
that could treat depression and other disorders. The company is likely to
expedite the development of this Phase II compound in order to launch it in
2004 (thus the higher R&D expenses). We know very little about this compound
at this point.

This was discussed in the call; and sounded like a potential blockbuster new generation anti-depressant. Has sepr been keeping this as an ace-in-the-hole? Anyone have prior knowledge? Thoughts?



To: LLCF who wrote (4573)10/19/2000 10:40:27 AM
From: Bob L  Read Replies (1) | Respond to of 10280
 
Where is the Blind Squirrel when we need him? This looks like his kind of nut.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News